339 related articles for article (PubMed ID: 25986135)
1. Underuse and Overuse of Osteoporosis Screening in a Regional Health System: a Retrospective Cohort Study.
Amarnath AL; Franks P; Robbins JA; Xing G; Fenton JJ
J Gen Intern Med; 2015 Dec; 30(12):1733-40. PubMed ID: 25986135
[TBL] [Abstract][Full Text] [Related]
2. US Preventative Services Task Force FRAX threshold has a low sensitivity to detect osteoporosis in women ages 50-64 years.
Bansal S; Pecina JL; Merry SP; Kennel KA; Maxson J; Quigg S; Thacher TD
Osteoporos Int; 2015 Apr; 26(4):1429-33. PubMed ID: 25614141
[TBL] [Abstract][Full Text] [Related]
3. Incidence and Predictors of Repeat Bone Mineral Densitometry: A Longitudinal Cohort Study.
White VanGompel EC; Franks P; Robbins JA; Fenton JJ
J Gen Intern Med; 2017 Oct; 32(10):1090-1096. PubMed ID: 28634907
[TBL] [Abstract][Full Text] [Related]
4. Targeted assessment of fracture risk in women at midlife.
Davis SR; Tan A; Bell RJ
Osteoporos Int; 2015 Jun; 26(6):1705-12. PubMed ID: 25630574
[TBL] [Abstract][Full Text] [Related]
5. Adherence and efficacy of screening for low bone mineral density among ulcerative colitis patients treated with corticosteroids.
Khan N; Abbas AM; Almukhtar RM; Cole EB; Khan AN
Am J Gastroenterol; 2014 Apr; 109(4):572-8. PubMed ID: 24469613
[TBL] [Abstract][Full Text] [Related]
6. Adherence to the U.S. Preventive Services Task Force 2002 osteoporosis screening guidelines in academic primary care settings.
Powell H; O'Connor K; Greenberg D
J Womens Health (Larchmt); 2012 Jan; 21(1):50-3. PubMed ID: 22150154
[TBL] [Abstract][Full Text] [Related]
7. Access to osteoporosis treatment is critically linked to access to dual-energy x-ray absorptiometry testing.
Cadarette SM; Gignac MA; Jaglal SB; Beaton DE; Hawker GA
Med Care; 2007 Sep; 45(9):896-901. PubMed ID: 17712261
[TBL] [Abstract][Full Text] [Related]
8. Bone health in women with premature ovarian insufficiency/early menopause: a 23-year longitudinal analysis.
Jones AR; Enticott J; Ebeling PR; Mishra GD; Teede HT; Vincent AJ
Hum Reprod; 2024 May; 39(5):1013-1022. PubMed ID: 38396142
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of a two-step population-based osteoporosis screening program using FRAX: the randomized Risk-stratified Osteoporosis Strategy Evaluation (ROSE) study.
Rubin KH; Rothmann MJ; Holmberg T; Høiberg M; Möller S; Barkmann R; Glüer CC; Hermann AP; Bech M; Gram J; Brixen K
Osteoporos Int; 2018 Mar; 29(3):567-578. PubMed ID: 29218381
[TBL] [Abstract][Full Text] [Related]
10. Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement.
; Curry SJ; Krist AH; Owens DK; Barry MJ; Caughey AB; Davidson KW; Doubeni CA; Epling JW; Kemper AR; Kubik M; Landefeld CS; Mangione CM; Phipps MG; Pignone M; Silverstein M; Simon MA; Tseng CW; Wong JB
JAMA; 2018 Jun; 319(24):2521-2531. PubMed ID: 29946735
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of fracture prevention in rural women with limited access to dual-energy X-ray absorptiometry.
Ito K; Leslie WD
Osteoporos Int; 2015 Aug; 26(8):2111-9. PubMed ID: 25807913
[TBL] [Abstract][Full Text] [Related]
12. Non-participation in systematic screening for osteoporosis-the ROSE trial.
Rothmann MJ; Möller S; Holmberg T; Højberg M; Gram J; Bech M; Brixen K; Hermann AP; Glüer CC; Barkmann R; Rubin KH
Osteoporos Int; 2017 Dec; 28(12):3389-3399. PubMed ID: 28875257
[TBL] [Abstract][Full Text] [Related]
13. Has Choosing Wisely® affected rates of dual-energy X-ray absorptiometry use?
Lasser EC; Pfoh ER; Chang HY; Chan KS; Bailey JC; Kharrazi H; Weiner JP; Dy SM
Osteoporos Int; 2016 Jul; 27(7):2311-2316. PubMed ID: 26860499
[TBL] [Abstract][Full Text] [Related]
14. Simplifying screening for osteoporosis in Australian primary care: the Prospective Screening for Osteoporosis; Australian Primary Care Evaluation of Clinical Tests (PROSPECT) study.
Davis SR; Kirby C; Weekes A; Lanzafame A; Piterman L
Menopause; 2011 Jan; 18(1):53-9. PubMed ID: 20711081
[TBL] [Abstract][Full Text] [Related]
15. Appropriateness of bone density measurement in Switzerland: a cross-sectional study.
Zechmann S; Scherz N; Reich O; Brüngger B; Senn O; Rosemann T; Neuner-Jehle S
BMC Public Health; 2018 Apr; 18(1):423. PubMed ID: 29606111
[TBL] [Abstract][Full Text] [Related]
16. Underuse of procedures for diagnosing osteoporosis and of therapies for osteoporosis in older nursing home residents.
Gupta G; Aronow WS
J Am Med Dir Assoc; 2003; 4(4):200-2. PubMed ID: 12837141
[TBL] [Abstract][Full Text] [Related]
17. Declining rates of osteoporosis management following fragility fractures in the U.S., 2000 through 2009.
Balasubramanian A; Tosi LL; Lane JM; Dirschl DR; Ho PR; O'Malley CD
J Bone Joint Surg Am; 2014 Apr; 96(7):e52. PubMed ID: 24695929
[TBL] [Abstract][Full Text] [Related]
18. Use of FRAX as a determinant for risk-based osteoporosis screening may decrease unnecessary testing while improving the odds of identifying treatment candidates.
Edwards FD; Grover ML; Cook CB; Chang YH
Womens Health Issues; 2014; 24(6):629-34. PubMed ID: 25128036
[TBL] [Abstract][Full Text] [Related]
19. Early menopause and risk of osteoporosis, fracture and mortality: a 34-year prospective observational study in 390 women.
Svejme O; Ahlborg HG; Nilsson JÅ; Karlsson MK
BJOG; 2012 Jun; 119(7):810-6. PubMed ID: 22531019
[TBL] [Abstract][Full Text] [Related]
20. BFH-OST, a new predictive screening tool for identifying osteoporosis in postmenopausal Han Chinese women.
Ma Z; Yang Y; Lin J; Zhang X; Meng Q; Wang B; Fei Q
Clin Interv Aging; 2016; 11():1051-9. PubMed ID: 27536085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
